1Department of Emergency Medicine, Dong-A University Hospital, Dong-A University College of Medicine, Busan, Korea
2Department of Intensive Care Medicine, Dong-A University Hospital, Dong-A University College of Medicine, Busan, Korea
Copyright © 2022 The Korean Society of Critical Care Medicine
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
CONFLICT OF INTEREST
No potential conflict of interest relevant to this article was reported.
AUTHOR CONTRIBUTIONS
Conceptualization: DHL. Data curation: DHL. Formal analysis: JEK. Methodology: all authors. Project administration: all authors. Visualization: all authors. Writing–original draft: JEK. Writing–review and editing: all authors.
Outcome | Value (n=78) |
---|---|
Discharged to home | 5 (6.4) |
Transferred to another hospital | 47 (60.3) |
Expired | 26 (33.3) |
Characteristics | Value (n=78) |
---|---|
Age (yr) | 71.9±11.5 |
Sex | |
Male | 49 (62.8) |
Female | 29 (37.2) |
Height (cm) | 163.3±9.6 |
Weight (kg) | 56.4±12.1 |
Admission department | |
Pulmonology | 46 (59) |
Cardiology | 7 (9) |
Nephrology | 5 (6.4) |
Gastroenterology | 4 (5.1) |
Other | 16 (20.5) |
APACHE II score | 25.9±5.8 |
Mechanical ventilation during PDT | |
On mechanical ventilation | 50 (64.1) |
Mean FiO2 (%) (n=50) | 40 (30–40) |
Duration from mechanical ventilation to PDT (day) | 14.0±7.5 |
Vasopressor therapy | 17 (21.8) |
Anticoagulant/antiplatelet treatment within 7 days | 30 (38.5) |
Anticoagulation duration before PDT (day) | 2.0 (2.0–3.3) |
Complication | Value (n=78) |
---|---|
Hypoxia | 4 (5.2) |
Conversion to surgical tracheostomy | 2 (2.6) |
Subglottic airway device insertion | 2 (2.6) |
Hypotension | 16 (20.5) |
Crystalloid replacement only | 8 (10.3) |
Vasopressor treatment only | 4 (5.1) |
Both crystalloid replacement and vasopressor therapy | 4 (5.1) |
Bleeding | 5 (6.4) |
Major bleeding | 0 |
Minor bleeding | 5 (6.4) |
Outcome | Value (n=78) |
---|---|
Discharged to home | 5 (6.4) |
Transferred to another hospital | 47 (60.3) |
Expired | 26 (33.3) |
Age (yr)/sex | Underlying disease | Reason for MV | Duration from MV to PDT (day) | PDT course | Complications during PDT | Special note |
---|---|---|---|---|---|---|
65/F | NSCLC (adenocarcinoma) | Pneumonia, atelectasis | 15 | 1st attempt failure | Hypoxia (SpO2, 67%) | |
2nd attempt success | ||||||
59/M | Olivopontocerebellar atrophy | Postoperative care (gastric ulcer perforation) | 19 | 1st attempt failure | Hypoxia (SpO2, 76%) | Heparinization |
2nd attempt success | Tracheostomy site obstruction | for CRRT | ||||
48/F | Alcoholic liver cirrhosis | Postoperative care (liver transplantation) | 23 | 1st attempt failure | Hypoxia (SpO2, 75%) | Thrombocytopenia (platelet count, 38,000/μl) |
2nd surgical tracheostomy | Bloody secretion from E-tube | |||||
84/M | Hypertension, diabetes mellitus | Postoperative care (spinal stenosis) | 20 | 1st attempt failure | Hypoxia (SpO2, 79%) | |
2nd attempt failure | ||||||
3rd surgical tracheostomy |
Values are presented as mean±standard deviation, number (%), or median (interquartile range). PDT: percutaneous dilatational tracheostomy; APACHE: Acute Physiology and Chronic Health Evaluation.
Values are presented as number (%). PDT: percutaneous dilatational tracheostomy.
Values are presented as number (%). PDT: percutaneous dilatational tracheostomy.
PDT: percutaneous dilatational tracheostomy; MV: mechanical ventilation; NSCLC: non-small-cell lung carcinoma; CRRT: continuous renal replacement therapy; E-tube: endotracheal tube.